UK steelmakers said US President Donald Trump’s decision to double import taxes on steel and aluminium to 50% is “yet another body blow” to the industry.
Archives
UN Warns: Iran Dramatically Boosts Near-Weapons Uranium Stockpile
Iran has further stepped up its production of highly enriched uranium, according to the UN nuclear watchdog, which set out “serious concern” at the development.
US Defense Chief: ‘Imminent’ China Threat to Taiwan Needs Asia Military Boost
US Secretary of Defense Pete Hegseth has warned of China posing an “imminent” threat to Taiwan, while urging Asian countries to boost defence spending and work with the US to deter war.
EU Slams Trump’s Double Steel Tariffs, Warns of Response
The EU has said it “strongly” regrets Donald Trump’s surprise plan to double US tariffs on steel and aluminium in a move that risks throwing bilateral trade talks into chaos.
Ryanair CEO Michael O’Leary Set for Potential €100m+ Bonus
Ryanair boss Michael O’Leary is on track to pocket bonuses worth more than €100m in what could reportedly mark one of the biggest pay-outs in European corporate history.
Boost Your Health & Mind: The Powerful Benefits of Daily Stair Climbing
While it is tempting to take the lift or escalator rather than use the stairs, even scaling just a few flights a day could give your health and mind a boost.
Big Tech Inertia Fuels ‘Industrial Scale’ Live Sport Piracy, Report Finds
A lack of action by big tech firms is enabling the “industrial scale theft” of premium video services, especially live sport, a new report says.
NatWest: Taxpayer Ownership Ends. Are UK Banks Safer?
The Treasury has announced the sale of its final shares in the NatWest Group. It means the bank will be under full private ownership, almost two decades after it was bailed out by the taxpayer amid the 2008 financial crisis.
Inside North Korea’s Secret Information War: Is Kim Jong Un Winning?
Listen to Jean read this article
Major Breakthrough: Immunotherapy Doubles Cancer-Free Time in Head & Neck Cancer
Hundreds of thousands of people with advanced head and neck cancer could live longer without their cancer returning thanks to an immunotherapy drug, a clinical trial suggests.